Healthtech Investors & VC Firms in Europe
1121 firms in this list, with a median first check of $540K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
7 people
Danone Manifesto Venture
New York CitySeed–Growth
11 people
Joa Capital
DiriyahPre-Seed–Series A$1M – $35M
8 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
Magnetic Ventures
BostonSeed–Series A$1M – $6M
9 people
MC Healthcare Ventures
CambridgeSeed–Series A
6 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries A–Late Stage
15 people
Audere Capital
RidgefieldSeries A–Late Stage
18 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
12 people
Propel Bio Partners
Los AngelesSeed–Series A
17 people
AEON Foundry
New York CityPre-Seed–Seed
8 people
Invus
New YorkPre-Seed–Late Stage
8 people
Mubadala Capital
Abu DhabiSeries A–Late Stage$1M – $50M
5 people
Laerdal Million Lives Fund
San FranciscoSeries A–Series B$1M – $5M
10 people
Marketplace
San FranciscoPre-Seed–Series A$100K – $250K
4 people
Infinitas Capital
Pre-Seed–Late Stage
17 people
Flow Capital
TorontoGrowth–Late Stage
1 person
Overwater Ventures Llc
Palo AltoPre-Seed–Series A$400K – $2M
7 people
CVC Asia Pacific (Japan) Kabushiki Kaisha
TokyoSeries B–Late Stage
11 people
Origins
MiamiPre-Seed–Series A$100K – $500K
5 people
ORI Capital
Hong KongPre-Seed–Late Stage
15 people
Star51 Capital
New York
16 people
The Riverside Company
ClevelandGrowth
13 people
Beast Ventures
Hong KongSeed
2 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.













)
)
)











































































